Literature DB >> 33259112

Ultrasound Controlled Anti-Inflammatory Polarization of Platelet Decorated Microglia for Targeted Ischemic Stroke Therapy.

Yujie Li1, Xucong Teng1, Chunrong Yang1, Yongji Wang1, Lingxiao Wang1, Yicong Dai1, Hua Sun1, Jinghong Li1.   

Abstract

Stroke is a lethal cerebral disease with severe sequelae and high mortality. Microglia, the main immune cell in the cerebrum, possess therapeutic potential for strokes as its specific anti-inflammatory phenotype can reduce inflammation and promote neuron regeneration. However, the on-demand anti-inflammatory polarization of microglia at the stroke site is uncontrollable for therapeutic application. Here, we develop a platelet hybrid microglia platform which can specifically polarize to the anti-inflammatory phenotype by ultrasound irradiation for targeted cerebrum repair after stroke. The engineered microglia have strong adherence to the injured cerebral vessels with platelet membrane fusion and realize on-demand anti-inflammatory polarization with ultrasound-responsive IL-4 liposome decoration. The intravenously injected microglia platform showed anti-inflammatory polarization at the stroke site with insonation, and accelerated the M2-type polarization of endogenous microglia for long-term stroke recovery. Satisfied prognoses were achieved with reduced apoptosis, promoted neurogenesis, and functional recovery, indicating the implications of the microglia platform for stroke therapy.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  cell polarization; ischemic stroke; microglia; nanotechnology; ultrasound

Mesh:

Substances:

Year:  2021        PMID: 33259112     DOI: 10.1002/anie.202010391

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  8 in total

Review 1.  The heterogeneity of microglial activation and its epigenetic and non-coding RNA regulations in the immunopathogenesis of neurodegenerative diseases.

Authors:  Chaoyi Li; Jie Ren; Mengfei Zhang; Huakun Wang; Fang Yi; Junjiao Wu; Yu Tang
Journal:  Cell Mol Life Sci       Date:  2022-09-06       Impact factor: 9.207

Review 2.  Cell-derived extracellular vesicles and membranes for tissue repair.

Authors:  Yuan Ding; Yanjie Li; Zhongquan Sun; Xin Han; Yining Chen; Yao Ge; Zhengwei Mao; Weilin Wang
Journal:  J Nanobiotechnology       Date:  2021-11-17       Impact factor: 10.435

Review 3.  Progresses and Prospects of Neuroprotective Agents-Loaded Nanoparticles and Biomimetic Material in Ischemic Stroke.

Authors:  Junfa Chen; Jing Jin; Kaiqiang Li; Lin Shi; Xuehua Wen; Fuquan Fang
Journal:  Front Cell Neurosci       Date:  2022-04-11       Impact factor: 5.505

Review 4.  Transcranial ultrasound stimulation applied in ischemic stroke rehabilitation: A review.

Authors:  Jiecheng Guo; Wai Leung Ambrose Lo; Huijing Hu; Li Yan; Le Li
Journal:  Front Neurosci       Date:  2022-07-22       Impact factor: 5.152

5.  Moderate-Intensity Ultrasound-Triggered On-Demand Analgesia Nanoplatforms for Postoperative Pain Management.

Authors:  Xinye Song; Mengxiao Luan; Weiyi Zhang; Ruizheng Zhang; Li Xue; Yong Luan
Journal:  Int J Nanomedicine       Date:  2022-07-23

Review 6.  Clickable Biomaterials for Modulating Neuroinflammation.

Authors:  Chase Cornelison; Sherly Fadel
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

7.  An ischemia-homing bioengineered nano-scavenger for specifically alleviating multiple pathogeneses in ischemic stroke.

Authors:  Ranran Duan; Ke Sun; Fang Fang; Ning Wang; Ruya He; Yang Gao; Lijun Jing; Yanfei Li; Zhe Gong; Yaobing Yao; Tingting Luan; Chaopeng Zhang; Jinwei Zhang; Yi Zhao; Haojie Xie; Yongyan Zhou; Junfang Teng; Jinfeng Zhang; Yanjie Jia
Journal:  J Nanobiotechnology       Date:  2022-08-31       Impact factor: 9.429

Review 8.  The Specific Role of Reactive Astrocytes in Stroke.

Authors:  Leiyang Li; Jinpeng Zhou; Liying Han; Xun Wu; Yingwu Shi; Wenxing Cui; Shenghao Zhang; Qing Hu; Jin Wang; Hao Bai; Haixiao Liu; Wei Guo; Dayun Feng; Yan Qu
Journal:  Front Cell Neurosci       Date:  2022-03-07       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.